Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

Xu, Chengchao; Wong, Yin Kwan; Liao, Fu Long; Jiang, Tingliang; Wang, Jigang; Tu, Youyou

Xu, Chengchao; Wong, Yin Kwan; Liao, Fu Long; Jiang, Tingliang; Wang, Jigang; Tu, Youyou.

Afiliação

Xu C; Shenzhen People's Hospital, Shenzhen, China; Artemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
Wong YK; Shenzhen People's Hospital, Shenzhen, China.
Liao FL; Artemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
Jiang T; Artemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
Wang J; Shenzhen People's Hospital, Shenzhen, China; Artemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China. Electronic address: jgwang@icmm.ac.cn.
Tu Y; Artemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.

Lancet Infect Dis ; 22(5): 585-586, 2022 05.

Article em En | MEDLINE | ID: mdl-35460649

Assuntos

Antimaláricos; Artemisininas; Malária Falciparum; Malária; Antimaláricos/uso terapêutico; Artemisininas/uso terapêutico; Combinação de Medicamentos; Quimioterapia Combinada; Humanos; Malária/tratamento farmacológico; Malária Falciparum/tratamento farmacológico; Plasmodium falciparum

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Malária Falciparum / Artemisininas / Malária / Antimaláricos Limite: Humans Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google